227 related articles for article (PubMed ID: 27760780)
1. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
[TBL] [Abstract][Full Text] [Related]
2. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
Cherry JD; Xing DX; Newland P; Patel K; Heininger U; Corbel MJ
Clin Infect Dis; 2004 Feb; 38(4):502-7. PubMed ID: 14765342
[TBL] [Abstract][Full Text] [Related]
3. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
[No Abstract] [Full Text] [Related]
5. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
6. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
Orr B; Douce G; Baillie S; Parton R; Coote J
Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
[TBL] [Abstract][Full Text] [Related]
7. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.
Wang X; Gray MC; Hewlett EL; Maynard JA
J Biol Chem; 2015 Feb; 290(6):3576-91. PubMed ID: 25505186
[TBL] [Abstract][Full Text] [Related]
8. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis.
Arciniega JL; Hewlett EL; Johnson FD; Deforest A; Wassilak SG; Onorato IM; Manclark CR; Burns DL
J Infect Dis; 1991 Jan; 163(1):135-42. PubMed ID: 1984460
[TBL] [Abstract][Full Text] [Related]
9. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
10. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
[TBL] [Abstract][Full Text] [Related]
12. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
13. Review of the neutrophil response to Bordetella pertussis infection.
Eby JC; Hoffman CL; Gonyar LA; Hewlett EL
Pathog Dis; 2015 Dec; 73(9):ftv081. PubMed ID: 26432818
[TBL] [Abstract][Full Text] [Related]
14. Western blot analysis of antibody responses of young infants to pertussis infection.
Guiso N; Grimprel E; Anjak I; Bégué P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658
[TBL] [Abstract][Full Text] [Related]
15. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
Nagel J; de Graaf S; Schijf-Evers D
Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
[TBL] [Abstract][Full Text] [Related]
16. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
Khosravani A; Parker MC; Parton R; Coote J
Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
[TBL] [Abstract][Full Text] [Related]
17. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination.
Farfel Z; Könen S; Wiertz E; Klapmuts R; Addy PA; Hanski E
J Med Microbiol; 1990 Jul; 32(3):173-7. PubMed ID: 2374155
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
Mobberley-Schuman PS; Connelly B; Weiss AA
J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
[TBL] [Abstract][Full Text] [Related]
20. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
Marley PB; Wilson JV; Habel H; Blaskett A
Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
